Thursday, April 24, 2025 | 07:04 AM ISTहिंदी में पढें
Abbott India Ltd News
Nifty Pharma tanks 3% on Trump's tariff threat; Zydus, Lupin down upto 10%
The decline in pharma stocks followed comments from President Donald Trump, who indicated that the US may impose tariffs of around 25 per cent on pharmaceutical, automobile, and semiconductor imports
 "Nifty Pharma tanks 3% on Trump's tariff threat; Zydus, Lupin down upto 10%")
Updated On : 19 Feb 2025 | 9:54 AM IST
Abbott India gains 10% in 2 days after posting healthy Q3 show; Details
The company's Q3 profit increased 16 per cent year-on-year (Y-o-Y) to Rs 360.78 crore as compared to Rs 310.98 crore
 "Abbott India gains 10% in 2 days after posting healthy Q3 show; Details")
Updated On : 06 Feb 2025 | 1:11 PM IST
Abbott India share rises 3% as JPMorgan ups target to Rs 31,500; details
The surge in Abbott India share price followed reports that JPMorgan, a New York-based financial services firm, raised its target price to Rs 31,500, up from Rs 30,000, signaling an upside of 12%
 "Abbott India share rises 3% as JPMorgan ups target to Rs 31,500; details")
Updated On : 19 Dec 2024 | 1:44 PM IST
Nifty Pharma jumps over 2%: Analysts decode the drivers behind the rally
Individually, Cipla soared up to 3.68 per cent to hit an intraday high of Rs 1,547.70 per share, while Sun Pharma soared up to 3.30 per cent to hit an intraday high of Rs 1,791.60 per share
 "Nifty Pharma jumps over 2%: Analysts decode the drivers behind the rally")
Updated On : 29 Nov 2024 | 12:37 PM IST
